Keros Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery and development of novel treatments for hematological and musculoskeletal disorders.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!